Suppression of SAMSN1 Expression is Associated with the Malignant Phenotype of Hepatocellular Carcinoma.

Satoshi Sueoka,Mitsuro Kanda,Hiroyuki Sugimoto,Dai Shimizu,Shuji Nomoto,Hisaharu Oya,Hideki Takami,Kazuhiro Ezaka,Ryoji Hashimoto,Yuri Tanaka,Yukiyasu Okamura,Suguru Yamada,Tsutomu Fujii,Goro Nakayama,Masahiko Koike,Michitaka Fujiwara,Yasuhiro Kodera

Suppression of SAMSN1 Expression is Associated with the Malignant Phenotype of Hepatocellular Carcinoma.

2015

Satoshi Sueoka
Mitsuro Kanda
Hiroyuki Sugimoto
Dai Shimizu
Shuji Nomoto
Hisaharu Oya
Hideki Takami
Kazuhiro Ezaka
Ryoji Hashimoto
Yuri Tanaka
Yukiyasu Okamura
Suguru Yamada
Tsutomu Fujii
Goro Nakayama
Masahiko Koike
Michitaka Fujiwara
Yasuhiro Kodera

Background Identification of molecular markers for sensitive detection of hepatocellular carcinoma (HCC) is required to achieve efficacious personalized therapy.

Keywords:

Pathology
Hepatocellular carcinoma
General surgery
Phenotype
Multiple myeloma
Medicine
malignant phenotype
Surgical oncology
Internal medicine
personalized therapy
Oncology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations